F-group (family)
5050.1.1.9 MFS_1
Ligands and drugs
6,308
Member domains
246
with ligand contacts (≤ 4 Å)
3.9% of members
91
with DrugDomain annotations
1.4% of members
63
with a DrugBank compound
1.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5050.1.1.9 belongs to X-group 5050 Major facilitator superfamily (MFS) general substrate transporter, which binds 9.9 ligand superclasses per 20 proteins, broader than 93% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02451 | BNG | B-nonylglucoside | 21 |
| DB00119 | — | Pyruvic acid | 14 |
| DB14475 | 2OP | L-Lactic acid | 6 |
| DB02024 | HCI | 3-phenylpropionic acid | 4 |
| DB03619 | DXC | Deoxycholic acid | 4 |
| DB14026 | JKE | Thiosalicylic acid | 4 |
| DB00446 | CLM | Chloramphenicol | 3 |
| DB01862 | IPT | Isopropyl beta-D-thiogalactopyranoside | 2 |
| DB09338 | — | — | 2 |
| DB12529 | NO2 | Nitrite | 2 |
| DB13180 | GCO | Gluconic Acid | 2 |
| DB00493 | — | Cefotaxime | 1 |
| DB03279 | LMU | Dodecyl-Alpha-D-Maltoside | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| YHR | reserpine | 26 |
| BNG | nonyl beta-D-glucopyranoside | 23 |
| SRO | SEROTONIN | 11 |
| G6P | 6-O-phosphono-alpha-D-glucopyranose | 10 |
| EBZ | (3S,5R,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one | 8 |
| 2OP | (2S)-2-HYDROXYPROPANOIC ACID | 6 |
| A1H2V | [(2~{R})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadecanoyloxy-propyl] octadecanoate | 6 |
| HSM | HISTAMINE | 6 |
| LDP | L-DOPAMINE | 6 |
| LMU | DODECYL-ALPHA-D-MALTOSIDE | 6 |
| A1IET | (2~{R},3~{R})-2-[(2~{S},3~{R})-3-(hydroxymethyl)-2-(3-methoxy-4-oxidanyl-phenyl)-7-oxidanyl-2,3-dihydro-1-benzofuran-5-yl]-3,5,7-tris(oxidanyl)-2,3-dihydrochromen-4-one | 5 |
| 02Q | 3-(2-methylphenyl)propanoic acid | 4 |
| 1HN | 1-hydroxynaphthalene-2-carboxylic acid | 4 |
| 1WE | (2S)-1-phenylpropan-2-amine | 4 |
| A1ATG | (2S)-3-{[(R)-[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryl]oxy}-2-{[(2E,9E,13E)-hexadeca-2,9,13-trienoyl]oxy}propyl (4E,9E,11Z,15E)-octadeca-4,9,11,15-tetraenoate | 4 |
| A1EG7 | (1S,3R,4R,5R)-3-[(E)-3-[3,4-bis(oxidanyl)phenyl]prop-2-enoyl]oxy-1,4,5-tris(oxidanyl)cyclohexane-1-carboxylic acid | 4 |
| BG6 | 6-O-phosphono-beta-D-glucopyranose | 4 |
| DU0 | 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol | 4 |
| DXC | (3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID | 4 |
| FIV | naphthalene-2-carboxylic acid | 4 |